Prime Medicine, Inc. Financial Overview
Prime Medicine, Inc.'s market cap is currently $657.06M. The company's EPS TTM is $-0.32; its P/E ratio is -2.47; Prime Medicine, Inc. is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
